BioSpace News Archive

Business

Medtronic names new chief scientific, medical, and regulatory officer

Medtronic plc announced that Laura Mauri, M.D., M.S.c. has been appointed Medtronic Chief Scientific, Medical and Regulatory Officer.

April 25, 2022
·
4 min read
BioMidwest

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

ZIVO Bioscience, Inc. announced that it received a Notice from Nasdaq that the Company has regained compliance of Nasdaq Listing Rule 5250.

April 25, 2022
·
1 min read
Business

PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today reported financial results for its third quarter ended February 28, 2022, and provided recent business highlights and update.

April 25, 2022
·
7 min read
Business

Adge Pharmaceuticals partners with Cyan Bio of Korea to advance treatments for rare pediatric diseases in Asian countries

Adge Pharmaceuticals (“Adge”) has entered into a license agreement with Korea-based Cyan Bio, Inc. (“Cyan”).

April 25, 2022
·
2 min read
FDA Clearance Granted for New Dual Lumen Catheter That Enables Precise Visualization and Treatment Access to the Left Heart

Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and delivery of cardiovascular catheters and guidewires to the heart chambers via transseptal puncture.

April 25, 2022
·
3 min read
Biotech Bay

Nkarta Announces Pricing of Upsized Public Offering of Common Stock - Apr 26, 2022

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $15.00 per share.

April 25, 2022
·
4 min read